Revolution Medicines is rated a Hold due to valuation concerns, uncertain acquisition prospects, and solo commercialization.
Zacks Investment Research on MSN
RVMD stock rises on detailed results from pancreatic cancer study
Shares of Revolution Medicines RVMD were rising in pre-market today after the company reported full results from the phase ...
A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...
FDA opens expanded access to daraxonrasib for metastatic pancreatic cancer, as phase 3 data boost survival and clinics race ...
Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in ...
The annual Prospectors & Developers Association of Canada (PDAC) convention is returning this year from March 3 to 6, and it comes as countries around the world take steps to secure supply of key ...
TORONTO, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The Prospectors & Developers Association of Canada (PDAC) is pleased to announce that registration for the PDAC 2025 Convention, taking place March 2-5, 2025 ...
The annual Prospectors & Developers Association of Canada (PDAC) convention is returning this year from March 1 to 4, and it comes at a significant time for the global resource sector. Precious metals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results